| ²é¿´: 518 | »Ø¸´: 1 | ||
| ±¾Ìû²úÉú 1 ¸ö ·ÒëEPI £¬µã»÷ÕâÀï½øÐв鿴 | ||
СÍèÍè9Ìú³æ (ÕýʽдÊÖ)
|
[ÇóÖú]
Çó·ÒëÒ»¾ä»°£¬Ð»Ð»
|
|
|
The studies are being conducted in a patient population at risk for CV clinical events. Primary endpoints are clinical endpoints or prevention of arrhythmias in post-MI patients; Tg-lowering is not an efficacy measure |
» ²ÂÄãϲ»¶
081700ѧ˶£¬323·Ö£¬Ò»Ö¾Ô¸Öйúº£Ñó´óѧÇóµ÷¼ÁѧУ
ÒѾÓÐ8È˻ظ´
283Çóµ÷¼Á
ÒѾÓÐ4È˻ظ´
²ÄÁϹ¤³Ì310ר˶µ÷¼Á
ÒѾÓÐ3È˻ظ´
Ò»Ö¾Ô¸±±¾©»¯¹¤085600 310·ÖÇóµ÷¼Á
ÒѾÓÐ10È˻ظ´
081700£¬311£¬Çóµ÷¼Á
ÒѾÓÐ6È˻ظ´
282Çóµ÷¼Á
ÒѾÓÐ5È˻ظ´
Ò»Ö¾Ô¸9²ÄÁÏѧ˶297ÒѹýÁù¼¶Çóµ÷¼ÁÍÆ¼ö
ÒѾÓÐ9È˻ظ´
278Çóµ÷¼Á
ÒѾÓÐ10È˻ظ´
301Çóµ÷¼Á
ÒѾÓÐ4È˻ظ´
085600£¬×¨Òµ¿Î»¯¹¤ÔÀí£¬321·ÖÇóµ÷¼Á
ÒѾÓÐ11È˻ظ´

ssssllllnnnn
ÖÁ×ðľ³æ (ÖªÃû×÷¼Ò)
Translator and Proofreader
- ·ÒëEPI: 1690
- Ó¦Öú: 452 (˶ʿ)
- ½ð±Ò: 31580.9
- ºì»¨: 100
- Ìû×Ó: 7681
- ÔÚÏß: 19966.6Сʱ
- ³æºÅ: 3328089
- ×¢²á: 2014-07-17
- רҵ: Ö×Áö·¢Éú
2Â¥2015-08-24 11:34:49














»Ø¸´´ËÂ¥